Stockreport

Inhibrx: The Biotech Spinoff Poised For Big Gains [Forbes]

Inhibrx Biosciences, Inc.  (INBX) 
PDF As an investor, my greatest returns have usually come from areas most people ignore. I concentrate on companies that analysts hardly cover or those spun off from more e [Read more]